General Information of the m6A Target Gene (ID: M6ATAR00736)
Target Name Signal transducer and activator of transcription 5A (STAT5A)
Gene Name STAT5A
Chromosomal Location 17q21.2
Family Transcription factor STAT family
Function
Carries out a dual function: signal transduction and activation of transcription. Mediates cellular responses to the cytokine KITLG/SCF and other growth factors. Mediates cellular responses to ERBB4. May mediate cellular responses to activated FGFR1, FGFR2, FGFR3 and FGFR4. Binds to the GAS element and activates PRL-induced transcription. Regulates the expression of milk proteins during lactation.
    Click to Show/Hide
Gene ID 6776
Uniprot ID
STA5A_HUMAN
HGNC ID
HGNC:11366
Ensembl Gene ID
ENSG00000126561
KEGG ID
hsa:6776
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
STAT5A can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
YTH domain-containing family protein 2 (YTHDF2) [READER]
In total 1 item(s) under this regulator
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene [1]
Response Summary The analyses of m6A-RIP-seq and RIP-PCR indicated that Signal transducer and activator of transcription 5A (STAT5A) was the downstream target of YTHDF2, which was binding to the m6A modification site of STAT5A to promote its mRNA degradation. ChIP-seq and PCR assays revealed that STAT5A suppressed multiple myelomacell proliferation by occupying the transcription site of MAP2K2 to decrease ERK phosphorylation.
Target Regulation Down regulation
Responsed Disease Multiple myeloma ICD-11: 2A83.1
Pathway Response MAPK signaling pathway hsa04010
Multiple myeloma [ICD-11: 2A83]
In total 1 item(s) under this disease
Experiment 1 Reporting the m6A-centered Disease Response [1]
Response Summary The analyses of m6A-RIP-seq and RIP-PCR indicated that Signal transducer and activator of transcription 5A (STAT5A) was the downstream target of YTHDF2, which was binding to the m6A modification site of STAT5A to promote its mRNA degradation. ChIP-seq and PCR assays revealed that STAT5A suppressed multiple myelomacell proliferation by occupying the transcription site of MAP2K2 to decrease ERK phosphorylation.
Responsed Disease Multiple myeloma [ICD-11: 2A83.1]
Target Regulator YTH domain-containing family protein 2 (YTHDF2) READER
Target Regulation Down regulation
Pathway Response MAPK signaling pathway hsa04010
References
Ref 1 YTHDF2 promotes multiple myeloma cell proliferation via STAT5A/MAP2K2/p-ERK axis. Oncogene. 2022 Mar;41(10):1482-1491. doi: 10.1038/s41388-022-02191-3. Epub 2022 Jan 24.